[
    [
        {
            "time": "",
            "original_text": "[买入-A评级]智飞生物(300122)季报点评：业绩略超预期 多个重磅品种助推公司未来高成长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "季报",
                    "业绩",
                    "超预期",
                    "重磅品种",
                    "高成长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入-A评级]智飞生物(300122)季报点评：业绩略超预期 多个重磅品种助推公司未来高成长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)季报点评：HPV疫苗和三联苗销售驱动公司业绩快速增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "HPV疫苗",
                    "三联苗",
                    "销售",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)季报点评：HPV疫苗和三联苗销售驱动公司业绩快速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)季报点评：预防微卡申报生产 一季度业绩高增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "预防微卡",
                    "申报生产",
                    "一季度",
                    "业绩高增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)季报点评：预防微卡申报生产 一季度业绩高增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "生物疫苗龙头企业纷纷晒业绩 这些个股被券商“强推”",
            "features": {
                "keywords": [
                    "生物疫苗",
                    "龙头企业",
                    "业绩",
                    "券商推荐"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物疫苗龙头企业纷纷晒业绩 这些个股被券商“强推”",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "数据王：21只个股逆势创出历史新高 医药股占据一半",
            "features": {
                "keywords": [
                    "数据王",
                    "个股",
                    "历史新高",
                    "医药股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "数据王：21只个股逆势创出历史新高 医药股占据一半",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：新产品相继上市助力后续发力 增持评级",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新产品",
                    "上市",
                    "后续发力",
                    "增持评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：新产品相继上市助力后续发力 增持评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]